JP Morgan Chase’s Viela Bio, Inc. Common Stock VIE Stock Holding History

JP Morgan Chase’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,222,052	Closed	-$44M	–	6544
2020 Q4	$44M	Buy	1,222,052 +38,228	+3%	+$1.34M	0.01%	1140
2020 Q3	$32.7M	Buy	1,183,824 +197,188	+20%	+$6.98M	0.01%	1197
2020 Q2	$42.7M	Buy	986,636 +128,517	+15%	+$5.82M	0.01%	964
2020 Q1	$32.6M	Sell	858,119 -20,835	-2%	-$812K	0.01%	993
2019 Q4	$23.9M	Buy	+878,954	New	+$22.2M	﹤0.01%	1445

JP Morgan Chase's VIE Position: Q1 2021 in Review

JP Morgan Chase sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 1,222,052 shares — an estimated $44M sold.

JP Morgan Chase first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $44M in Q4 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

JP Morgan Chase reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
JP Morgan Chase sold 1,222,052 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $44M.
JP Morgan Chase first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
JP Morgan Chase's Viela Bio, Inc. Common Stock position peaked at $44M in Q4 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.